Author(s): Farmer J
Diabetes is a highly prevalent disease in the United States and is increasing in both incidence and prevalence. Atherosclerotic vascular disease is a major cause of morbidity and mortality in diabetic patients. Type 2 diabetes is characterized by insulin resistance and frequently co-exists with a variety of cardiovascular risk factors, including hypertension, obesity, dyslipidemia, and physical inactivity. Hygienic measures such as weight loss and exercise should form the basis of therapeutic interventions in the prevention and treatment of type 2 diabetes. The role of dyslipidemia as a causal factor in vascular disease associated with diabetes was previously downplayed because total cholesterol was frequently normal or minimally elevated. However, diabetic dyslipidemia is characterized by elevated triglycerides, low high-density lipoprotein, and small, dense low-density lipoprotein, the combination of which has been termed the "lipid triad." The role of lipid modification as a means to decrease cardiovascular risk in type 2 diabetes has recently been clarified by a number of clinical trials. Subgroup analysis in early studies implied the potential for benefit of lipid modification in diabetes. The results of these early studies prompted the design of large-scale intervention trials that employed statin and fibric acid derivatives in diabetes patients. The preponderance of data from the statin trials implicates significant clinical benefit in cardiovascular risk reduction. The fibric acid derivatives have theoretic advantages in diabetic dyslipidemia. However, the robust bulk of clinical data obtained from prospective statin studies is lacking for the fibric acid derivatives, and the results of the major trials are equivocal.
Referred From: https://www.ncbi.nlm.nih.gov/pubmed/18367002
Author(s): Ponte C
Author(s): Mensing C, Boucher J, Cypress M, Weinger K, Mulcaby K, et al.
Author(s): Parving HH, Lehnert H, Bröchner-Mortensen J, Gomis R, Andersen S, et al.
Author(s): Foreyt JP, Poston WS 2nd
Author(s): Baliga BS, Fonseca VA (l997) Recent advances in the treatment of type II diabetes mellitus
Author(s): Bailey CJ, Turner RC
Author(s): Mann JF
Author(s): Stang M, Wysowski DK, Butler-Jones D
Author(s): Whittemore R
Author(s): Wing RR, Anglin K
Author(s): DeFronzo RA
Author(s): Wen LK, Shepherd MD, Parchaman ML
Author(s): Savoca MR, Miller CK, Quandt SA
Author(s): Turner R, Cull C, Holman R
Author(s): Arc A, Korhonen T, Halinen M
Author(s): Somogyi A, Stockley C, Keal J, Rolan P, Bockner F (1 987) Reduction of metformin renal tubular secretion by cimetidine in man
Author(s): Lubbos H, Miller JL, Rose LI
Author(s): Yeap BB
Author(s): Kubacka RT, Antal EJ, Juhi RP, Weishman IR (1 996) Effects of aspirin and ibuprofen on the pharmacokinetics and pharmacodynamics of glyburide in healthy subjects
Author(s): Christensen LK, Hansen J, Kristensen M
Author(s): Kivisto KT, Neuvonen PJ
Author(s): Ben-Ami H, Nagachandran P, Mendelson A, Edoute Y
Author(s): Nelson KM, Reiber G, Boyko EJ, Nhanes III
Author(s): Huang CL, Wu SC, Jeng CY, Lin LC
Author(s): Hurley CC, Shea CA
Author(s): Aljasem LI, Peyrot M, Wissow L, Rubin RR
Author(s): Diabetes Control and Complications Trial Research Group
Author(s): Ohkubo Y, Kishikawa H, Araki E, Myata T, Isami S, et al.
Author(s): Swift CS, Armstrong JE, Berman KA, Cambell RK, Pond-Smith D
Author(s): Polit DF, Hungler BP
Author(s): Gerich JE, Odawara M, Terauchi Y
Author(s): Bergenstal RM, Gavin JR, Global Consensus conference on Glucose monitoring panel
Author(s): Renard E
Author(s): Tan MY, Magarey J
Author(s): Mastura I, Mimi O, Piterman L, Teng CL, Wijesinha S
Author(s): Ismail IS, Nazaimoon W, Mohamad W, Letchuman R, Hew FL, et al.
Author(s): Pahor M, Psaty BM, Alderman MH, Applegate WB, Williamson JD, et al.
Author(s): Samuel-Hodge CD, Fernandez LM, Henrfquez-Roldan CF, Johnston LF, Keyserling TC
Author(s): Subar AF, Kipnis V, Troiano RP, Midthune D, Schoeller DA, et al.
Author(s): Boehm S, Schlenk EA, Funnell MM, Powers H, Ronis DL
Author(s): Travis T
Author(s): Wen LK, Parchman ML, Shepherd MD
Author(s): Bantle JP, Wylie-Rosett J, Albright AL, Apovian CM, Clark NG, et al.
Author(s): Nutrition sub-committee of the diabetes Care Advisory Committee of Diabetes UK
Author(s): Stein CJ, Colditz GA
Author(s): Hadaegh F, Ghasemi A, Padyab M, Tohidi M, Azizi F
Author(s): Dalgård C, Thurøe A, Haastrup B, Haghfelt T, Stender S
Author(s): Christian JG, Bessesen DH, Byers TE, Christian KK, Goldstein MG, et al.
Author(s): Heshka S, Greenway F, Anderson JW, Atkinson RL, Hill JO, et al.
Author(s): Cefalu WT
Author(s): Plosker G, Faulds D
Author(s): Caldwell MA, Peters Kj, Dracup KA
Author(s): Vincent D, Pasvogel A, Barrera L
Author(s): Tan SL, Yong LS, Wan S, Wong ML
Author(s): Hawthone K
Author(s): Middlekoop B, van der Wal G
Author(s): Kulzer B, Hermanns n, Reinecker H, Haak T
Author(s): Clark M, Hampson SE, Avery L, Simpson R
Author(s): Brown S
Author(s): Deakin T, Cade J, Williams R, Greenwood D
Author(s): Raji A, Gomes H, Beard JO, MacDonald P, Conlin PR
Author(s): Clement S
Author(s): Elasy T, Ellis S, Brown A, Pichert J
Author(s): Rubin RR
Author(s): Evans J, Newton R, Ruta D, MacDonald T, Stevenson R, et al.
Author(s): Rhee MK, Slocum W, Ziemer DC, Culler SD, Cook CB, et al.
Author(s): Murata G, Shah J, Duckworth W, Wendel C, Mohler M, et al.
Author(s): Krass I, Armour CL, Mitchell B, Brilliant M, Dienaar R, et al.
Author(s): Suppapitiporn S, Chindavijak B, Onsanit S
Author(s): Welschen LM, Bloemendal E, Nijpels G, Dekker J, Heine RJ, et al.
Author(s): Arcury TA, Preisser JS, Gesler WM, Powers JM
Author(s): Strauss K, MacLean C, Troy A, Littenberg B
Author(s): Westaway MS, Seager JR, Rheeder P, Van Zyl DG
Author(s): Khoo KL, Liew YM, Tan H, Sambhi JS, Hatijah BA
Author(s): Leong KC, Chen WS, Leong KW, Mastura I, Mimi O, et al.